PORTFOLIO NEWS RAPT Therapeutics Reports First Quarter 2023 Financial Results May 11, 2023 Read More » Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 10, 2023 Read More » Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates May 10, 2023 Read More » Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction May 10, 2023 Read More » eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 9, 2023 Read More » NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 May 8, 2023 Read More » ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates May 8, 2023 Read More » Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress May 8, 2023 Read More » NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data May 4, 2023 Read More » Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting May 3, 2023 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 10, 2023 Read More »
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates May 10, 2023 Read More »
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction May 10, 2023 Read More »
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 9, 2023 Read More »
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 May 8, 2023 Read More »
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates May 8, 2023 Read More »
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress May 8, 2023 Read More »
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data May 4, 2023 Read More »
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting May 3, 2023 Read More »
